Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Oct 2.
Published in final edited form as: Subst Abus. 2017 Jul 20;38(4):493–497. doi: 10.1080/08897077.2017.1355870

Post-discharge smoking cessation in subgroups of hospitalized smokers: a latent class analysis.

Thomas Ylioja 1, Gerald Cochran 2, Yuchiao Chang 3, Hilary A Tindle 4, Nancy A Rigotti 5
PMCID: PMC6168063  NIHMSID: NIHMS1507569  PMID: 28727541

Abstract

Background:

Hospitalization presents a window of opportunity to treat smoking, and hospital-initiated smoking treatment has demonstrated effectiveness. Despite effective interventions, not all smokers will discontinue use, highlighting the need to better understand which patients achieve cessation. Traditional regression methods may not capture the complexity of inpatient smoker subgroups.

Methods:

We conducted latent class analysis (LCA) with data from 397 hospitalized adult cigarette smokers enrolled in a randomized trial. Six categorical indicator variables known to impact cessation were selected to estimate subgroups: health conditions (smoking-related disease (SRD), depressive symptoms, positive screen for alcohol problems) and smoking-related variables (time to first cigarette, cigarettes/day, smoking indoors). We estimated the probability of achieving biologically-verified seven-day tobacco cessation six months after discharge.

Results:

A three-class model best fit the trial data: a Light Smokers subgroup had lower probability for most indicators; a High Health Burden subgroup had high smoking behavior probabilities and similar health problems to the Light Smokers subgroup; and a Heavy Smoking Drinking Depressed subgroup had high nicotine dependence, depressive symptoms, and alcohol misuse probabilities. Probability of biologically-verified cessation conditional on class membership was significantly higher (p<0.001) for the High Health Burden and the Light Smokers subgroups compared to the Heavy Smoking Drinking Depressed subgroup.

Conclusion:

Results suggest that subgroups with lower probabilities of alcohol misuse and depression and higher probability of SRD had higher probability of successful cessation after hospital discharge. Hospitalized patients with nicotine dependence combined with behavioral and mental health problems have additional cessation barriers that may require intervention focus.

INTRODUCTION:

Hospitalization presents a window of opportunity to provide cessation interventions to smokers. Illness motivates smokers to quit, hospitals are smoke-free environments that encourage short-term abstinence, and treatment initiated in the hospital and continued after discharge increases long-term cessation.1 While the evidence for hospital-initiated treatment is robust, not every smoker will achieve long-term cessation even with intensive treatment and follow-up, highlighting the need to understand which patient subgroups achieve cessation.

Previous research has demonstrated that successful smoking cessation is predicted by various factors including smoking-related characteristics and health conditions. Smoking behaviors, including the nicotine dependence markers of time to first cigarette after waking and the number of cigarettes consumed per day, can predict cessation.2 Having a home indoor smoking ban has been shown to increase cessation;3 potentially important for patients returning home from hospital. Vulnerability to and diagnosis of smoking-related diseases (SRD) can increase successful cessation among medically ill smokers,4,5 while behavioral and mental health problems such as alcohol misuse and depression lower the likelihood of success.6,7 Complex intersections of multiple cessation predictors has not previously been tested among smokers receiving hospital-initiated interventions.

Complex patient subgroups, defined by patterns of predictors, are insufficiently identified using traditional multiple regression moderation analyses.8 Null hypothesis testing may inadequately capture the complex relationship between the outcome and predictors that influence each other compared with statistical models developed to best fit observed data.8 Additionally, testing predictors of clinical trial outcomes using null hypothesis tests for pre-specified groups is susceptible to Type I error and often involves conservative statistical corrections.9

Latent class analysis (LCA) is an informative method of predicting outcomes among patient subgroups10 and has been used to evaluate brief alcohol interventions for hospitalized patients11 as well as cessation for tobacco interventions.12,13 LCA hypothesizes that a latent (i.e., unobserved) categorical variable predicted by multiple observed variables describes patient subgroups known as classes.14 LCA captures the variability of multiple patient characteristics by finding shared patterns of responses, then assigns each individual a class value based upon the probability that class best captures their unique characteristics.14

The objective of this study was to estimate the presence of latent patient subgroups among a sample of hospitalized smokers using multiple cessation predictors. A model of latent subgroups that best fit the observed cessation predictors could be used to understand which patterns predict achieving cessation.

METHOD:

Participants and Design

Data for this secondary analysis were collected in a randomized cessation intervention trial provided after hospital discharge. Participants were 397 adult daily smokers admitted to an academic teaching hospital who received cessation counseling during their stay, planned to quit post-discharge, and were willing to accept cessation medication. Study recruitment and intervention methods have been described in detail.15 Patients were randomized into either standard care (n=199; received inpatient counseling, given specific recommendation for post-discharge medication and counseling but post-discharge treatment not provided automatically), or a sustained care (n=198; standard care plus provided with up to three months free medication and interactive voice response telephonic counseling for medication use and support). Patients were contacted at one, three, and six months post-discharge to complete follow-up assessments. The primary outcome for the trial was biologically-verified past seven-day tobacco cessation at six months post-discharge. The sustained care intervention was superior to standard care for use of post-discharge smoking cessation treatment, and for cessation (relative risk=1.71, 95% CI: 1.14 – 2.56).16

Measures

Smoking cessation was defined in the parent study.15,16 Self-reported (yes/no) past seven-day smoking was assessed during follow-up surveys. Cessation at six months was verified by saliva cotinine, or expired air CO if still using nicotine replacement. Missing self-report outcomes and failure to complete the biological verification test were considered current smoking.

Six indicators were selected from the available baseline trial data and considered important to cessation based upon prior research demonstrating an association between the cessation predictor (indicator) and cessation (outcome), as reviewed above. These indicators represented three smoking-related variables and three health conditions that altogether were linked as cessation predictors to form patient subgroups in this clinical trial.

The smoking variables included two markers of nicotine dependence:2 cigarettes per day (≤10 vs.>10) and time to first cigarette (≤30 vs. > 30 minutes), as well as presence of a home smoking ban (“Does anyone smoke in your home?” yes/no). The three health status binary (yes/no) indicators included any discharge diagnosis of SRD, positive screen for alcohol use problems, and positive screen for depressive symptoms. SRD was defined using ICD-9-CM codes corresponding to the 2014 U.S. Surgeon General’s Report for cancer, cardiovascular disease, pulmonary disease, and perinatal conditions.17 A positive screen for alcohol use problems was defined by scores ≥4 for males or ≥3 for females on the 3-item Alcohol Use Disorders Identification Test (AUDIT-C, range: 0–12).18 A positive screen for depressive symptoms was defined by a score ≥7 on the 8-item Center for Epidemiological Studies Depression scale (CESD-8, range: 0–24).19

Analysis

LCA to identify subgroups of participants was conducted with the six indicator variables using Mplus 7.4 (Mplus, Los Angeles, CA) with a distal categorical outcome.20 The optimal number of subgroups was identified using an iterative process of increasing the number of subgroups until best fit was achieved using the Akaike Information Criterion (AIC), sample-size adjusted Bayesian Information Criterion (aBIC), and the bootstrapped likelihood ratio test (BLRT).21 The highest posterior probability for each patient determined subgroup assignment, and the average probability in each subgroup provided a measure of assignment accuracy. Posterior probability values closer to 1 indicate better agreement between observed patient data and the subgroup response pattern. The biologically-verified smoking cessation primary outcome and secondary self-report cessation outcomes were added using Lanza’s approach22 to test whether the probability of cessation varied by subgroup. Equality of outcome distributions across subgroups was tested using Wald’s chi-square test. Differences in patient characteristics were compared across assigned subgroups using ANOVA for continuous variables and chi-square tests for categorical variables. A three-step approach accounting for LCA measurement error using multinomial logistic regression20 confirmed these differences (Supplemental Table 1). The xxx Institutional Review Board reviewed and approved this secondary analysis as exempt.

RESULTS:

A latent variable with three subgroups was found using model fit criteria (Supplemental Table 2) with entropy of 0.623 (BLRT p=0.013). Subgroup labels describe the pattern of affirmative responses (Figure 1). Baseline demographics are displayed in Table 1. The Light Smokers subgroup (n=140, 35.3%) was characterized by lower probabilities of smoking dependence, depressive symptoms, and alcohol use problems. Light Smokers had class assignment accuracy of 0.816 on average. Patients were on average age 52.5 years, 79% were White, 49% reported more than high school education, and 46% randomized to sustained care.

Figure 1.

Figure 1.

Latent class conditional item affirmative response probabilities.

Table 1.

Baseline Characteristics and Smoking Cessation Outcome by Subgroups

Total
Sample
Light
Smokers
High
Health
Burden
Heavy
Smoking
Drinking
Depressed
p
N (%) 399 140 (35.3) 230 (57.9) 27 (6.8)
Age, mean (SD) 52.5 (12.1) 52.5 (12.4) 53.9 (10.9) 41.4 (14.1) <0.001
Gender, % Female 48.6 58.6 48.3 40.7 0.081
Race, % White 81.1 79.3 90.8 74.1 0.002
Education, % High school or less 51.5 50.7 51.5 55.6 0.899
Intervention study arm, % 49.9 45.7 52.6 48.2 0.43
>10 cigarettes smoked per day, % 67.8
Smoke within 30 minutes, % 77.6
Home smoking ban, % 38.7
Smoking related diagnosis, % 45.2
Alcohol use problems, % 36.6
Depressive symptoms, % 65.5
Conditional probability (SE) of cessation outcome
1 month self-report 0.686 (0.09) 0.451 (0.07) 0.248 (0.1) 0.006
3 month self-report 0.541 (0.18) 0.414 (0.04) 0.27 (0.12) 0.555
6 month self-report 0.804 (0.27) 0.353 (0.06) 0.132 (0.08) 0.013
6 month biologically confirmed 0.435 (0.14) 0.206 (0.05) 0.003 (0.04) <0.001

SD=standard deviation, SE=standard error.

a

Items scaled from 1–10; 1 = lowest score, 10 = highest score.

The High Health Burden subgroup was the largest (n=230, 57.9%) characterized by high probability of smoking risks and SRD but slightly lower probability of depressive symptoms and alcohol use problems. Class assignment accuracy was 0.861 on average. These patients were slightly, though not significantly, older than the Light Smokers subgroup; 48% were female; significantly more were White (91%), 49% had more than high school education, and 53% randomized to sustained care.

Finally, the Heavy Smoking Drinking Depressed subgroup (n=27, 6.8%) characterized individuals with high levels of smoking dependence, symptoms of depression and alcohol use problems, but lower probability of smoking inside their home and having SRD. Class assignment accuracy was 0.755 on average. Patients in this subgroup were significantly younger (41 years) than the other subgroups; 41% were female, 74% were White; 44% had more than high school education, and 48% randomized to sustained care.

The conditional probability of biologically-verified cessation was significantly different (Wald χ2(df=2)=18.3, p<.0001) across subgroups. The probability of verified cessation at six-month follow-up was 0.435 (SE=0.14) in the Light Smokers subgroup, 0.206 (SE=0.05) in the High Health Burden subgroup, and 0.003 (SE=0.043) in the Heavy Smoking Drinking Depressed subgroup. In pairwise comparisons, Light Smokers had the highest probability of smoking cessation, but not significantly different from the High Health Burden subgroup. The Heavy Smoking Drinking Depressed subgroup had a significantly lower probability of smoking cessation compared to both the Light Smokers and High Health Burden subgroups. For the self-reported smoking cessation outcomes, there were significant differences at one month between the Light Smokers and Heavy Smoking Drinking Depressed subgroups, and at six months between the Heavy Smoking Drinking Depressed and both the Light Smokers and High Health Burden subgroups (Table 1).

DISCUSSION:

Three subgroups of hospitalized smokers were found using LCA with six cessation predictors observed in a clinical trial. While randomization into study arm did not differ significantly, subgroups had significantly different probabilities of achieving verified smoking cessation at six-month follow-up. Comparing these subgroups, for hospitalized patients a lower probability of depressive symptoms and alcohol use problems, and higher probability of SRD was associated with greater success of achieving cessation. While each of these indicators independently predicts cessation in the general population, the combined pattern strongly predicted cessation outcomes for hospitalized smokers. The two largest subgroups (High Health Burden vs. Light Smokers) differed in the probability of smoking behavior but had similar patterns of health conditions including depressive symptoms, alcohol use problems, and SRD (Figure 1). These patterns did not generate significant differences in cessation, whereas differences in cessation were predicted by differences in health conditions (High Health Burden and Light Smokers vs. Heavy Smoking Drinking Depressed subgroup).

The demographic subgroup analyses conducted for the parent study found a significant study interaction for non-White participants achieving cessation with sustained care.16 This current analysis found proportionally more racial minorities in subgroups with both the highest and the lowest probabilities of cessation. This suggests that differences in cessation after discharge may be more complex than demographics and based in part on patterns of cessation predictors.

Hospitalized smokers have complex needs and barriers to smoking cessation.5 Cessation predictors including markers of nicotine dependence,2 smoking inside the home,3 as well as comorbid physical, behavioral, and mental health concerns6,7 likely influence one another. Interest in personalized medical care using the right treatment for the right patient23 has generated biological risk prediction discoveries;24 however, personalized care and intervention tailoring require further knowledge about the differential treatment impact, particularly to address tobacco-related health disparities among patient subgroups.25 Using LCA, patient subgroups that represent patterns of predictors could be used to increase tobacco treatment effectiveness. For example, providers could input clinical data into a latent class algorithm that identifies the most effective treatment for a patient profile and provide a personalized care plan. As more patient data are accumulated, additional classes and treatment modalities could be evaluated creating a robust menu of interventions.

There are limitations to this study. This analysis was conducted post hoc from clinical trial data not collected to explore latent subgroups. In addition, latent subgroups are probabilistic with possible misclassification associated with attempts to categorize individuals. We did not control for significant differences in demographics in assessing the conditional outcome probabilities. Although covariates can be included in a single-step approach, this could change item response and class membership probabilities for the latent class variable.22 Alternatively, a classify-analyze approach using pseudoclass draws based on posterior probabilities26 or a three-step approach that accounts for class assignment error could control for covariates.27 In these models, class membership is assigned and outcomes added to the model with covariate controls; however, each approach has limitations related to assigning membership, compared to Lanza’s approach that estimates the conditional probability of the outcome based on the probability of class membership.20,22

In summary, hospitalization presents a window of opportunity to initiate smoking treatment and for individuals to make a cessation attempt.1 The complex relationship between smoking behaviors and comorbid health conditions predicted post-discharge cessation among subgroups of patients identified using latent class analysis (LCA). These findings offer unique insight into how cessation predictors intersect to create a patient profile and has potential to inform personalized care and intervention tailoring. While treatment guidelines for smoking recommend multiple modalities for the best cessation outcomes,28 LCA could be a useful tool in developing a profile-based approach to optimize cessation impact.

Supplementary Material

Supp1

Acknowledgments

Funding: The study was funded by NIH/NHLBI grant RC1-HL09966 to NR. The funding organization had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Footnotes

Blinded Material: Ethics statement; References 15 and 16.

The University of Pittsburgh Institutional Review Board reviewed and approved this secondary analysis study as exempt.

Contributor Information

Thomas Ylioja, School of Social Work, University of Pittsburgh, 2117 Cathedral of Learning, 4200 Fifth Avenue, Pittsburgh, PA 15260,.

Gerald Cochran, School of Social Work; Department of Psychiatry, University of Pittsburgh.

Yuchiao Chang, Department of Medicine, Harvard Medical School.

Hilary A. Tindle, Department of Medicine, Vanderbilt University.

Nancy A. Rigotti, Tobacco Research and Treatment Center, Massachusetts General Hospital, Department of Medicine, Harvard Medical School.

REFERENCES:

  • 1.Rigotti NA, Clair C, Munafo MR, Stead LF. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev 2012;5:CD001837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kozlowski LT, Porter CQ, Orleans CT, Pope MA, Heatherton T. Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI. Drug Alcohol Depend 1994;34(3):211–216. [DOI] [PubMed] [Google Scholar]
  • 3.Borland R, Yong HH, Cummings KM, Hyland A, Anderson S, Fong GT. Determinants and consequences of smoke-free homes: findings from the International Tobacco Control (ITC) Four Country Survey. Tob Control 2006;15 Suppl 3:iii42–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Borrelli B, Hayes RB, Dunsiger S, Fava JL. Risk perception and smoking behavior in medically ill smokers: a prospective study. Addiction 2010;105(6):1100–1108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Gregor K, Borrelli B. Barriers to quitting smoking among medically ill smokers. J Behav Med 2012;35(5):484–491. [DOI] [PubMed] [Google Scholar]
  • 6.Leeman RF, McKee SA, Toll BA, et al. Risk factors for treatment failure in smokers: relationship to alcohol use and to lifetime history of an alcohol use disorder. Nicotine Tob Res 2008;10(12):1793–1809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Zawertailo L, Voci S, Selby P. Depression status as a predictor of quit success in a real-world effectiveness study of nicotine replacement therapy. Psychiatry Res 2015;226(1):120–127. [DOI] [PubMed] [Google Scholar]
  • 8.Rodgers JL. The epistemology of mathematical and statistical modeling: a quiet methodological revolution. Am Psychol 2010;65(1):1–12. [DOI] [PubMed] [Google Scholar]
  • 9.Friedman L, Furberg C, DeMets D. Fundamentals of Clinical Trials 4th ed. New York, NY: Springer; 2010. [Google Scholar]
  • 10.Lanza ST, Rhoades BL. Latent class analysis: an alternative perspective on subgroup analysis in prevention and treatment. Prev Sci 2013;14(2):157–168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Cochran G, Field C, Foreman M, Ylioja T, Brown CV. Effects of brief intervention on subgroups of injured patients who drink at risk levels. Inj Prev 2016;22(3):221–225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Deiches JF, Baker TB, Lanza S, Piper ME. Early lapses in a cessation attempt: lapse contexts, cessation success, and predictors of early lapse. Nicotine Tob Res 2013;15(11):1883–1891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.McCarthy DE, Ebssa L, Witkiewitz K, Shiffman S. Paths to tobacco abstinence: A repeated-measures latent class analysis. J Consult Clin Psychol 2015;83(4):696–708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Collins L, Lanza ST. Latent class and latent transition analysis Hoboken, NJ: John Wiley & Sons, Inc; 2010. [Google Scholar]
  • 15.Japuntich SJ, Regan S, Viana J, et al. Comparative effectiveness of post-discharge interventions for hospitalized smokers: study protocol for a randomized controlled trial. Trials 2012;13:124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Rigotti NA, Regan S, Levy DE, et al. Sustained care intervention and postdischarge smoking cessation among hospitalized adults: a randomized clinical trial. JAMA 2014;312(7):719–728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.U.S. Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health;2014. [Google Scholar]
  • 18.Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med 1998;158(16):1789–1795. [DOI] [PubMed] [Google Scholar]
  • 19.Melchior LA, Huba GJ, Brown VB, Reback CJ. A short depression index for women. Educ Psychol Meas 1993;53(4):1117–1125. [Google Scholar]
  • 20.Asparouhov T, Muthén B. Auxiliary Variables in Mixture Modeling: Three-Step Approaches Using Mplus. Struct Equ Modeling 2014;21(3):329–341. [Google Scholar]
  • 21.Nylund KL, Asparouhov T, Muthén BO. Deciding on the number of classes in latent class analysis and growth mixture modeling: A Monte Carlo simulation study. Struct Equ Modeling 2007;14(4):535–569. [Google Scholar]
  • 22.Lanza ST, Tan X, Bray BC. Latent Class Analysis With Distal Outcomes: A Flexible Model-Based Approach. Struct Equ Modeling 2013;20(1):1–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.McClure JB, Swan GE, St John J, et al. Pharmacogenetic smoking cessation intervention in a health care setting: a pilot feasibility study. Nicotine Tob Res 2013;15(2):518–526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Bierut LJ, Johnson EO, Saccone NL. A glimpse into the future - Personalized medicine for smoking cessation. Neuropharmacology 2014;76 Pt B:592–599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Carlsten C, Halperin A, Crouch J, Burke W. Personalized medicine and tobacco-related health disparities: is there a role for genetics? Ann Fam Med 2011;9(4):366–371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Wang C- P, Hendricks Brown C, Bandeen-Roche K. Residual diagnostics for growth mixture models. J Am Stat Assoc 2005;100(471):1054–1076. [Google Scholar]
  • 27.Vermunt JK. Latent class modeling with covariates: Two improved three-step approaches. Polit Anal 2010;18(4):450–469. [Google Scholar]
  • 28.Fiore M, Jaén C, Baker T, et al. Treating Tobacco Use and Dependence: 2008 Update Rockville, MD: U.S. Department of Health and Human Services. Public Health Service; 2008. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supp1

RESOURCES